investigated. Endocytosed toxins initially accumulate in endosomes, where they may take advantage of 1 0 1 the acidic environment within the vesicles to form, or contribute to membrane damage in order to 1 0 2 translocate into the cytosol. Since LtxA binds to LFA-1, the possibility is that LtxA could be using 1 0 3 an integrin trafficking pathway to gain access to the target cell cytosol. Here we examined the 1 0 4 components of the cytosol of LtxA-treated cells for co-localization of the toxin and the CD11a subunit of 1 0 5 LFA-1 with different organelle markers. LtxA association with endosomal and lysosomal markers 1 0 6 suggests a receptor mediated endocytic process that may culminate in delivery of the toxin to 1 0 7 lysosomes. Additionally, the toxin can be redirected to the plasma membrane due to the LFA-1 receptor 1 0 8
Rab11a-mediated recycling. This study provides new insight into convergent mechanism of LFA-1 and 1 0 9
LtxA trafficking, and the ability of LtxA to function in acidic environments. 1 1 0 1 1 1 2. RESULTS 1 1 2 2.1. LtxA does not damage host cell membrane when enters the cell. The membrane damaging 1 1 3 properties of LtxA have been documented [32, 33] . Therefore, the first question we asked was whether 1 1 4 initial steps of LtxA interaction with the cells result in the plasma membrane damage. The green-1 1 5 fluorescent impermeable nucleic acid stain YO-PRO®-1 (630 kDA) is used to detect early membrane 1 1 6 damage and permeates cells immediately after membrane destabilization [34] . We performed flow 1 1 7 cytometry analysis of LtxA-treated cells to determine YO-PRO®-1 internalization to indicate plasma 1 1 8 membrane damage. The YO-PRO®-1 membrane permeabilization assay showed no evidence of 1 1 9 plasma membrane damage in LtxA treated Jn.9 cells within first 4 h of the treatment (Fig. 1 ). However, 1 2 0 our flow cytometry data demonstrate that 20 nM LtxA-DY488 become internalized with Jn.9 cells as 1 2 1 early as 15 min after the toxin was added and its internalization steadily increased over time. Our 1 2 2 results indicate that LtxA is quickly internalized by Jn.9 cells but the toxin does not rupture the plasma 1 2 3 membrane when it enters the host cells. 1 2 4 2.2. LtxA uptake is diminished by dynamin inhibitors. We used a set of chemical and 1 2 5 pharmacological inhibitors of endocytosis (Table 1) to define the mechanism of the toxin uptake by Jn.9 1 2 6 cells. Fluorescent-labeled toxin internalization was significantly reduced in cells pre-treated with 1 2 7 dynamin-inhibitors. To confirm the efficiency or specificity of selected dynamin inhibitors concentrations, 1 2 8 the internalization of transferrin labeled with Alexa Fluor®647 was followed using confocal microscopy. 1 2 9
Cells pretreated with 10 µM Dynasore and 5 µM Dynole 34-2, which block GTPase activity of dynamin 1 3 0 [35] [36], for 20 min were less susceptible to LtxA. However, the inhibitors affecting clathrin-mediated 1 3 1 endocytic pathway such as potassium depleted medium and 5 µM Pitstop 2 did not change activity of 1 3 2 LtxA on Jn.9 cells. This suggests that LtxA internalization in Jn.9 cells is dynamin-dependent (Fig. 2) . 1 3 3 2.3. LtxA and CD11a are found in early and recycling endosomes. Jn.9 cells treated with 1 3 4 fluorescent-labeled LtxA for 30 min were used to performing immunocytochemistry experiments with 1 3 5 endocytic pathway markers including GTPase Rab5 and Rab11a. The co-distribution of LtxA and LFA-1 1 3 6 heterodimer components on the surface of target cell membranes suggests that LtxA could gain access 1 3 7 to the cytosol as individual LtxA molecules or as part of an LtxA/LFA-1 complex. In our imaging studies 1 3 8
LtxA was found in vesicular structures after entry into Jn.9 cells. Our immunocytochemistry studies 1 3 9 demonstrated co-localization of LtxA, early endosome membrane protein Rab5a and CD11a 1 4 0 suggesting toxin uptake through receptor-mediated endocytosis. Fig. 3A and Fig. 1S -A show confocal 1 4 1 images of Jn.9 cells with co-localization of LtxA, CD11a, and early endosomal marker Rab5a after 1 4 2 treatment of the cells with LtxA-DY650 for 30 min at 37 0 C. We found co-localization of CD11a and LtxA 1 4 3 with recycling endosomal marker Rab11a in recycling endosomes. LFA-1 are exocytosed via GTPase 1 4 4
Rab11A-mediated recycling [37] a process that involves trafficking through the perinuclear recycling 1 4 5 compartment (PNRC), before reaching the plasma membrane. Co-localization of CD11a and LtxA with 1 4 6 recycling endosomal marker Rab11a in recycling endosomes ( Fig. 3B and Fig. 1S-B ) suggests that 1 4 7 after entering the early endosome a significant amount of LtxA is redirected back to the membrane in 1 4 8 LFA-1 recycling turnover. Alternatively, release of LtxA into PNRC can provide access to the nuclear 1 4 9 3 9 6 *To measure LtxA activity inhibition, Jn.9 cells were preincubated with 10 µM inhibitors for 20 min in 3 9 7 serum free medium. The chemicals stocks were prepared in DMSO and were added in the 1 µl volume 3 9 8 to 1 ml of cells. No adverse effect of DMSO alone on Jn.9 cells was observed. 3 9 9 4 0 0 distributions (see Fig. 3 ) or directly from the statistics of single-channel data (n number of single 4 0 7 events). To analyze the conductance in each case n channels were reconstituted in asolectin/n-decane 4 0 8 membranes at 20 mV voltage, t=20°C. The number of events analyzed at pH 3.7 and 10 was low due 4 0 9
to instability of the lipid bilayers at extreme pH. Flow cytometry analysis was used to detect YO-PRO®-1 and LtxA inside of Jn.9 cells over time. C 4 3 0
(1 × 10 6 ) were incubated with 10 µM YO-PRO®-1 alone or in presence of 20 nM LtxA. Another se 4 3 1 cells was treated with 20 nM LtxA-DY488 at different times. The extracellular fluorescence of the c 4 3 2 was quenched with 0.025% trypan blue [30] Jn.9 Cells (1 × 10 6 cells) were incubated in K + -containing (top) or K + -depleted buffer (bottom), and then 4 5 5 20 nM LtxA-DY488 was added for 30 min. Flow cytometry analysis to determine the amount of 4 5 6 internalized toxin (red peak) was performed as described in Fig. 2A . Untreated cells (black) served as a 4 5 7 negative control. Representative flow cytometry histograms are shown. 4 5 8 C. LtxA toxicity on Jn.9 cells. To measure LtxA activity inhibition, Jn.9 cells were preincubated with 4 5 9 10 µM inhibitors for 20 min in serum free medium at 37 °C, and then 10 nM LtxA was added and the 4 6 0 cells were incubated for 18 h. The cell viability was measured by the trypan blue assay. Confocal images showing localization of LtxA, CD11a, endosome or lysosome markers in Jn. 9 c 4 7 0 after treatment with the toxin for 30-120 min at 37 0 C. LtxA-DY650 is pseudo colored in green, CD 4 7 1 detected with mouse anti-CD11a antibody conjugated with Alexa Fluor TM 594 is shown in red, 4 7 2 KCl, 10 mM MES-KOH, pH 4.7 and 10 nM LtxA, the applied membrane potential was 20 mV, t=20°C. 5 3 1 C. Histogram of the probability P(G) for the occurrence of a given conductivity unit observed for LtxA 5 3 2 with membranes formed of 1% asolectin dissolved in n-decane in a salt solution at pH 6.0. The average 5 3 3 conductance of all conductance steps was 1.20 ± 0.31 nS for 95 conductance steps derived from 17 5 3 4 individual membranes. The aqueous phase contained 1 M KCl, 10 mM MES, pH 6.0 and about 10 nM 5 3 5
LtxA, the applied membrane potential was 20 mV, t=20°C. Confocal images showing localization of LtxA, CD11a, endosome or lysosome markers in Jn. 9 c 5 5 5 after treatment with the toxin for 30-120 min at 37 0 C. LtxA-DY650 is shown in cyan, CD11a detec 5 5 6 with mouse anti-CD11a antibody conjugated with Alexa Fluor TM 594 is shown in red, 5 5 7 cells tected , and endosomal/lysosomal markers detected through goat-anti rabbit antibody conjugated with DyLight TM 5 5 8 488 are shown in green. Cell nuclei were stained with Hoechst 33342 (blue). No significant background 5 5 9 fluorescence in unstained Jn.9 cells was detected. Representative images are shown. Scale bars = 5 6 0 2μm. 5 6 1 A. Localization of LtxA, CD11a and Rab5 after treatment of the cells with the toxin for 30 min. L  i  n  h  a  r  t  o  v  a  ,  I  .  ;  B  u  m  b  a  ,  L  .  ;  M  a  s  i  n  ,  J  .  ;  B  a  s  l  e  r  ,  M  .  ;  O  s  i  c  k  a  ,  R  .  ;  K  a  m  a  n  o  v  a  ,  J  .  ;  P  r  o  c  h  a  z  k  o  v  a  ,  K  .  ;  A  d  k  i  n  s  ,  I  . ; ; . 
